| abstract |
The present invention comprises the steps of: (a) measuring the expression level of the mRNA or protein thereof of one or more genes selected from the group consisting of EXOC3L2, KCNK6, SPRN, MRGPRX3, CERS3, LCAT, UPB1, or ZCCHC18 in a biological sample; And (b) adding a candidate material to the biological sample in the step (a), and selecting an anticancer agent when there is a change in the expression level of the mRNA or protein thereof of the genes. About. In addition, the present invention relates to a pharmaceutical composition for preventing or treating cancer comprising, as an active ingredient, a component capable of regulating the expression level of the mRNA or protein of the genes. |